Gene: [00.0/ITGA9] integrin, alpha 9; — Gene: [00.0/PRSS4] protease, serine, 4a (trypsin 4a, brain);

  • Gene: [00.0/ITGA9] integrin, alpha 9;
  • Gene: [00.0/ITGAE] integrin, alpha E, epithelial-associated (antigen CD103); human mucosal lymphocyte antigen 1; alpha polypeptide (antigen CD103);
  • Gene: [00.0/ITGAW] integrin, alpha W;
  • Gene: [00.0/ITGB5] integrin, beta 5;
  • Gene: [00.0/ITGB8] integrin, beta 8;
  • Gene: [00.0/ITPK1] inositol 1,3,4-trisphosphate 5/6 kinase;
  • Gene: [00.0/IV] inversus situs, viscerum;
  • Gene: [00.0/JTK5A] protein tyrosine kinase JTK5A;
  • Gene: [00.0/JTK5B] protein tyrosine kinase JTK5B;
  • Gene: [00.0/KAL2] Kallmann syndrome 2 (autosomal dominant; hypogonadotropic hypogonadism and anosmia);
  • Gene: [00.0/KAL3] Kallmann syndrome 3 (autosomal recessive; hypogonadotropic hypogonadism and anosmia);
  • Gene: [00.0/KCNA10] potassium voltage-gated channel, shaker-related subfamily, member 10;
  • Gene: [00.0/KCND1] potassium voltage-gated channel, Shal-related subfamily, member 1;
  • Gene: [00.0/KCND2] potassium voltage-gated channel, Shal-related subfamily, member 2;
  • Gene: [00.0/KCND3] potassium voltage-gated channel, Shal-related subfamily, member 3;
  • Gene: [00.0/KCNF] potassium voltage-gated channel, subfamily F;
  • Gene: [00.0/KCNG] potassium voltage-gated channel, subfamily G;
  • Gene: [00.0/KCNH1] potassium voltage-gated channel, subfamily H, member 1;
  • Gene: [00.0/KCNH2] potassium voltage-gated channel, subfamily H, member 2;
  • Gene: [00.0/KCNJ13] potassium inwardly-rectifying channel, subfamily J, member 13; [Kir1.4 Kir7.1 ]
  • Gene: [00.0/KCNJ14] potassium inwardly-rectifying channel, subfamily J, member 14; [IRK4 Kir2.4 ]
  • Gene: [00.0/KCNK2] potassium inwardly-rectifying channel, subfamily K, member 2; [TREK-1 ]
  • Gene: [00.0/KCNK3] potassium inwardly-rectifying channel, subfamily K, member 3; [TASK ]
  • Gene: [00.0/KCNN1] potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1; [SK1 ]
  • Gene: [00.0/KCNN2] potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2; [hSK2 ]
  • Gene: [00.0/KCNN4] potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4; [IK1 SK4 KCA4 ]
  • Gene: [00.0/KCNS1] potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1; [Kv9.1 ]
  • Gene: [00.0/KDELR1] KDEL (Lys-Asp-Glu-Leu) 72kD endoplasmic reticulum protein retention receptor 1; [ERD2.1 ]
  • Gene: [00.0/KDELR2] KDEL (Lys-Asp-Glu-Leu) 26kD endoplasmic reticulum protein retention receptor 2 (homolog of Yeast ERD2); [ERD2.2 ]
  • Gene: [00.0/KHS] kinase homologous to SPS1/STE20;
  • Gene: [00.0/KLRE] killer cell lectin-like receptor subfamily E (homologous to rat NKAP); [NKAP ]
  • Gene: [00.0/KMS] Kabuki make-up syndrome (Niikawa-Kuroki syndrome);
  • Gene: [00.0/KNPEP] lysyl aminopeptidase (aminopeptidase Co);
  • Gene: [00.0/KNS1A] kinesin 1, heavy chain, member A (110-120kD); [KNS1 KNS ]
  • Gene: [00.0/KNS1B] kinesin 1, heavy chain, member B (neuronal); [NKHC ]
  • Gene: [00.0/KNSL3] kinesin-like 3;
  • Gene: [00.0/KNSL4] kinesin-like 4 (73kD); kinesin-like DNA binding protein (Kid); [Kid OBP-1 ]
  • Gene: [00.0/KPNA1] karyopherin (importin) alpha 1 (SRP1-beta); RAG (recombination activating gene) cohort 2; suppressor of RNA polymerase I mutation (Saccharomyces) homolog; [RCH2 SRP1 ]
  • Gene: [00.0/KPNA4] karyopherin (importin) alpha 4; [Qip1 ]
  • Gene: [00.0/KPNA6] karyopherin (importin) alpha 6;
  • Gene: [00.0/KPNB1] karyopherin (importin) beta 1 (p97); [NTF97 ]
  • Gene: [00.0/KPNB2] karyopherin (importin) beta 2; transportin (M9-interacting protein); [MIP MIP1 TRN ]
  • Gene: [00.0/KPNB3] karyopherin (importin) beta 3;
  • Gene: [00.0/KRT11] keratin 11, type I, alpha, acidic (pI 5.3; 56kD); [CYKA11 ]
  • Gene: [00.0/KRT14P] keratin 14 pseudogene; [CYKA14P ]
  • Gene: [00.0/KRT15L] keratin 15-like;
  • Gene: [00.0/KRT16P1] keratin 16 pseudogene 1;
  • Gene: [00.0/KRT17P1] keratin 17 pseudogene 1;
  • Gene: [00.0/KRT17P2] keratin 17 pseudogene 2;
  • Gene: [00.0/KRT19P] keratin 19 pseudogene; [CYKA19P ]
  • Gene: [00.0/KRT20] keratin 20, type I, alpha, acidic;
  • Gene: [00.0/KRT2B] keratin 2B, type II, beta, basic (oral);
  • Gene: [00.0/KRT6C] keratin 6C, type II, beta, basic;
  • Gene: [00.0/KRT6D] keratin 6D, type II, beta, basic;
  • Gene: [00.0/KRT6E] keratin 6E, type II, beta, basic;
  • Gene: [00.0/KRT6F] keratin 6F, type II, beta, basic;
  • Gene: [00.0/KRTHA4] keratin, hair, acidic, 4; hard keratin, type I, 4; [Ha-4 ]
  • Gene: [00.0/KRTHB2] keratin, hair, basic, 2; hard keratin, type II, 2; [Hb-2 ]
  • Gene: [00.0/KRTHB4] keratin, hair, basic, 4; hard keratin, type II, 4; [Hb-4 ]
  • Gene: [00.0/KYN] kynureninase (L-kynurenine hydrolase); xanthurenicaciduria (kynureninase deficiency);
  • Gene: [00.0/LAG2] lymphocyte-activation gene 2;
  • Gene: [00.0/LAIR2] leukocyte-associated immunoglobulin-like receptor 2;
  • Gene: [00.0/LAMP2L1] lysosome-associated membrane protein 2-like 1;
  • Gene: [00.0/LAT] linker for activation of T and NK cells (36kD);
  • Gene: [00.0/LBC] lymphoid blast crisis oncogene (47kD);
  • Gene: [00.0/LFNG] lunatic fringe (Drosophila) homolog;
  • Gene: [00.0/LGALS4] lectin, galactoside-binding, soluble, 4; galectin 4 (36.3kD);
  • Gene: [00.0/LGALS5] lectin, galactoside-binding, soluble, 5; galectin 5;
  • Gene: [00.0/LGALS6] lectin, galactoside-binding, soluble, 6; galectin 6;
  • Gene: [00.0/LGALS8] lectin, galactoside-binding, soluble, 8; galectin 8; prostate carcinoma tumor antigen (PCTA-1); [PCTA-1 ]
  • Gene: [00.0/LGALS9] lectin, galactoside-binding, soluble, 9; galectin 9;
  • Gene: [00.0/LGTN] ligatin;
  • Gene: [00.0/LIMAB1] LIM actin binding protein 1; [abLIM ]
  • Gene: [00.0/LIMS1] LIM and senescent cell antigen-like domains 1; PINCH protein (particularly interesting new Cys-His protein); [PINCH ]
  • Gene: [00.0/LIPG] lipase, gastric;
  • Gene: [00.0/LKP] leukophysin;
  • Gene: [00.0/LLGL2] lethal giant larvae (Drosophila) homolog 2;
  • Gene: [00.0/LLP] lactation, late, protein (macropodids);
  • Gene: [00.0/LMO7] LIM domain only 7;
  • Gene: [00.0/LNPEP] leucyl aminopeptidase (EC:3.4.11.1); cystinyl aminopeptidase (oxytocinase; EC:3.4.11.3);
  • Gene: [00.0/LON1] ATP-dependent protease Lon 1 (bacterial Lon) homolog, mitochondrial;
  • Gene: [00.0/LON2] ATP-dependent protease Lon 2 (bacterial Lon) homolog, mitochondrial;
  • Gene: [00.0/LOXL2] lysyl oxidase-like 2;
  • Gene: [00.0/LPO] lactoperoxidase;
  • Gene: [00.0/LRMP] lymphoid-restricted membrane protein; lypmhoid protein of endoplasmic reticulum; [JAW1 ]
  • Gene: [00.0/LRP130] leucine-rich protein 130kD; [HLRP ]
  • Gene: [00.0/LSD] Letterer-Siwe disease;
  • Gene: [00.0/LTB4HD] leukotriene B4 12-hydroxydehydrogenase, NADP-dependent;
  • Gene: [00.0/LXR] orphan nuclear hormone receptor, retinoid response;
  • Gene: [00.0/LY75] lymphocyte antigen 75; [DEC-205 ]
  • Gene: [00.0/MAD2L1] human homolog of MAD2; MAD2 (mitotic arrest deficient, yeast, homolog)-like 1; [HSMAD2 ]
  • Gene: [00.0/MAFD1] major affective disorder 1; [MD1 ]
  • Gene: [00.0/MAM] Maghrebian myopathy (autosomal recessive);
  • Gene: [00.0/MAN1A1] mannosidase, alpha, class 1A, member 1; mannosidase, alpha type II, man9-;
  • Gene: [00.0/MANBB] mannosidase, beta B, soluble;
  • Gene: [00.0/MAPKAP2] mitogen-activated protein kinase-activated protein kinase 2;
  • Gene: [00.0/MARK1] MAP/microtubule affinity-regulating kinase 1; serine/threonine kinase MARK1;
  • Gene: [00.0/MASP2] mannose-binding protein-associated 2;
  • Gene: [00.0/MATN2] matrilin 2;
  • Gene: [00.0/MATN3] matrilin 3;
  • Gene: [00.0/MATR1] matrin 1 (major nuclear matrix protein);
  • Gene: [00.0/MATR3] matrin 3 (125kD; major nuclear matrix protein);
  • Gene: [00.0/MAZ] MYC-associated zinc finger protein (purine-binding transcription factor); [MAZI ZF87 Pur ]
  • Gene: [00.0/MCCA] methylcrotonyl-CoA carboxylase, alpha (MCCA deficiency); methylcrotonylglycinuria I (MCC deficiency I);
  • Gene: [00.0/MCCB] methylcrotonyl-CoA carboxylase, beta (MCCB deficiency); methylcrotonylglycinuria II (MCC deficiency II);
  • Gene: [00.0/MCCC1] methylcrotonoyl-Coenzyme A carboxylase 1 (alpha);
  • Gene: [00.0/MCCC2] methylcrotonoyl-Coenzyme A carboxylase 2 (beta); beta-methylcrotonylglycinuria I;
  • Gene: [00.0/MCMP] myeloma cell metalloproteinase; a disintegrin and metalloprotease domain 9; [ADAM12 ADAM9 ]
  • Gene: [00.0/MCO] microphthalmia (Los Angeles type);
  • Gene: [00.0/MEB] muscle-eye-brain disease; [MEB-D ]
  • Gene: [00.0/MEF2AP] MADS box transcription enhancer factor 2, polypeptide A pseudogene;
  • Gene: [00.0/MEKK3] MAP/ERK kinase kinase 3; MAP kinase kinase kinase 3;
  • Gene: [00.0/MERR] metalloregulatory DNA-binding protein;
  • Gene: [00.0/MGEA] meningioma expressed antigen; [MEA6 ]
  • Gene: [00.0/MHC2TA] MHC class II transactivator; MHC class II deficiency, complementation group A; bare lymphocyte syndrome, complementation group A (BLS; MIM:209920); [CIITA C2TA ]
  • Gene: [00.0/MIC2R] MIC2-related;
  • Gene: [00.0/MLANA] melan-A (melanoma antigen recognized by T-cells); [MART-1 ]
  • Gene: [00.0/MLK2] mixed lineage kinase 2 (tyr and ser/thr specificity);
  • Gene: [00.0/MLPL1] MARCKS-like protein-like 1;
  • Gene: [00.0/MLSN1] melastatin 1;
  • Gene: [00.0/MLT4] metallothionein 4;
  • Gene: [00.0/MMP16] matrix metalloproteinase 16 (membrane-inserted);
  • Gene: [00.0/MMP17] matrix metalloproteinase 17, membrane-type;
  • Gene: [00.0/MMP18] matrix metalloproteinase 18;
  • Gene: [00.0/MMSDH] methylmalonate-semialdehyde dehydrogenase;
  • Gene: [00.0/MOV34L] Moloney leukemia virus 34 proviral integration homolog-like;
  • Gene: [00.0/MPB2] MYC promoter-binding protein 2;
  • Gene: [00.0/MPST] mercaptopyruvate sulfurtransferase;
  • Gene: [00.0/MRE11B] meiotic recombination (S. cerevisiae) 11 homolog B;
  • Gene: [00.0/MSBP1] minisatellite binding protein 1;
  • Gene: [00.0/MSBP2] minisatellite binding protein 2 (77kD);
  • Gene: [00.0/MSBP3] minisatellite binding protein 3 (115kD);
  • Gene: [00.0/MSG1] melanocyte specific gene 1 (27kD);
  • Gene: [00.0/MSNL1] moesin-like 1;
  • Gene: [00.0/MSNL2] moesin-like 2;
  • Gene: [00.0/MTAPP] methylthioadenosine phosphorylase pseudogene;
  • Gene: [00.0/MTG] mesotrypsinogen (pancreatic);
  • Gene: [00.0/MTHFS] 5,10-methenyl-tetrahydrofolate synthase;
  • Gene: [00.0/MTIF2] mitochondrial translational initiation factor 2;
  • Gene: [00.0/MTNRL] melatonin receptor-like;
  • Gene: [00.0/MTRP] Golgi 4-transmembrane spanning transporter MTP; [KIAA0108 ]
  • Gene: [00.0/MUC18] mucin 18, melanoma-associated glycoprotein; melanoma adhesion molecule (CD146); [MCAM CD146 ]
  • Gene: [00.0/MUC24] mucin 24, multi glycosylated core protein;
  • Gene: [00.0/MUM1] multiple myeloma oncogene 1;
  • Gene: [00.0/MVD] mevalonate (diphospho) decarboxylase;
  • Gene: [00.0/MYCP] avian myelocytomatosis viral (v-myc) oncogene homolog pseudogene;
  • Gene: [00.0/MYD118] myeloid differentiation primary response gene (MYD118);
  • Gene: [00.0/MYHK] myosin, heavy polypeptide kinase;
  • Gene: [00.0/MYHL] myosin, heavy polypeptide-like (100kD);
  • Gene: [00.0/MYL6] myosin, light polypeptide 6, alkali; smooth muscle and non-muscle;
  • Gene: [00.0/MYO1B] myosin IB;
  • Gene: [00.0/MYO1E] myosin IE;
  • Gene: [00.0/MYO1F] myosin IF;
  • Gene: [00.0/MYO5B] myosin VB;
  • Gene: [00.0/MYO7B] myosin VIIB;
  • Gene: [00.0/MYO9A] myosin IXA;
  • Gene: [00.0/MYSA] myasthenic (Lambert-Eaton) syndrome antigen A; Lambert-Eaton myasthenic syndrome;
  • Gene: [00.0/MYT1L] myelin transcription factor 1-like;
  • Gene: [00.0/MYT1] myelin transcription factor 1; proteolipid protein binding protein 1; [PLPB1 ]
  • Gene: [00.0/NAB1] NGFI-A binding protein 1 (EGR1 binding protein 1);
  • Gene: [00.0/NACB] nascent-polypeptide-associated complex beta polypeptide;
  • Gene: [00.0/NAG2] novel antigen 2 (tetraspan); transmembrane 4 superfamily member ?;
  • Gene: [00.0/NAP1L1] nucleosome assembly protein 1-like 1 (NAP1-related protein 1); [NRP NAP1 ]
  • Gene: [00.0/NASP] nuclear autoantigenic sperm protein (histone-binding);
  • Gene: [00.0/NBP1] nucleotide binding protein (E.coli MinD like); [NBP ]
  • Gene: [00.0/NCAM2] neural cell adhesion molecule 2;
  • Gene: [00.0/NDUFA10] NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10 (42kD);
  • Gene: [00.0/NDUFA3] NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 (9kD, B9);
  • Gene: [00.0/NDUFA4] NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 (9kD; EC:1.6.5.3, EC:1.6.99.3);
  • Gene: [00.0/NDUFA8] NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 (19kD; EC:1.6.5.3, EC:1.6.99.3);
  • Gene: [00.0/NDUFA9] NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (39kD; EC:1.6.5.3, EC:1.6.99.3);
  • Gene: [00.0/NDUFAB1] NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 (8kD);
  • Gene: [00.0/NDUFB10] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 (22kD);
  • Gene: [00.0/NDUFB1] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1 (7kD);
  • Gene: [00.0/NDUFB2] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (8kD);
  • Gene: [00.0/NDUFB3] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3 (12kD);
  • Gene: [00.0/NDUFB4] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4 (15kD);
  • Gene: [00.0/NDUFB5] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 (16kD);
  • Gene: [00.0/NDUFB6] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (17kD);
  • Gene: [00.0/NDUFB7] NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (18kD; EC:1.6.5.3, EC:1.6.99.3); cell adhesion protein SQM1;
  • Gene: [00.0/NDUFC1] NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 (6kD);
  • Gene: [00.0/NDUFC2] NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (14.5kD);
  • Gene: [00.0/NDUFS3] NADH dehydrogenase (ubiquinone) Fe-S protein 3 (30kD; NADH-CoQ reductase);
  • Gene: [00.0/NDUFS4] NADH dehydrogenase (ubiquinone) Fe-S protein 4 (18kD; NADH-CoQ reductase);
  • Gene: [00.0/NDUFS5] NADH dehydrogenase (ubiquinone) Fe-S protein 5 (15kD; NADH-CoQ reductase);
  • Gene: [00.0/NDUFS6] NADH dehydrogenase (ubiquinone) Fe-S protein 6 (13kD; NADH-CoQ reductase);
  • Gene: [00.0/NEDD10] neural precursor cell expressed, developmentally down-regulated 10;
  • Gene: [00.0/NEDD3] neural precursor cell expressed, developmentally down-regulated 3;
  • Gene: [00.0/NEDD6] neural precursor cell expressed, developmentally down-regulated 6;
  • Gene: [00.0/NEDD7] neural precursor cell expressed, developmentally down-regulated 7;
  • Gene: [00.0/NEDD8] neural precursor cell expressed, developmentally down-regulated 8;
  • Gene: [00.0/NEDD9] neural precursor cell expressed, developmentally down-regulated 9;
  • Gene: [00.0/NEF3] neurofilament 3 (150kD medium);
  • Gene: [00.0/NEF4] neurofilament 4 (57kD);
  • Gene: [00.0/NEF5] neurofilament 5 (66kD);
  • Gene: [00.0/NES] nestin, cytoplasmic intermediate filament of central nervous system;
  • Gene: [00.0/NF1L2] neurofibromin 1-like 2;
  • Gene: [00.0/NF1L3] neurofibromin 1-like 3;
  • Gene: [00.0/NF1L4] neurofibromin 1-like 4;
  • Gene: [00.0/NF1L5] neurofibromin 1-like 5;
  • Gene: [00.0/NF1L6] neurofibromin 1-like 6;
  • Gene: [00.0/NFATC3] nuclear factor of activated T-cells, cytoplasmic 3; [NFAT4 NFATX ]
  • Gene: [00.0/NFATC4] nuclear factor of activated T-cells, cytoplasmic 4; [NFAT3 ]
  • Gene: [00.0/NFATC5] nuclear factor of activated T-cells, cytoplasmic 5;
  • Gene: [00.0/NFIL3] nuclear factor, interleukin 3 regulated (interleukin 3 binding); [IL3BP1 E4BP4 ]
  • Gene: [00.0/NFIXL3] nuclear factor I/X-like 3;
  • Gene: [00.0/NFKBIB] nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; transcription factor kappa-B, inhibitor, beta; [IKBB ]
  • Gene: [00.0/NFKBIE] nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon; transcription factor kappa-B, inhibitor, epsilon; [IKBE ]
  • Gene: [00.0/NFKBIL2] nuclear factor of kappa light chain gene enhancer in B-cells inhibitor-like 2; transcription factor kappa-B, inhibitor-like 2;
  • Gene: [00.0/NFX1] nuclear transcription factor, X-box binding 1;
  • Gene: [00.0/NINJ2] ninjurin 2;
  • Gene: [00.0/NKX2B] NK homeobox (Drosophila), family 2, B;
  • Gene: [00.0/NKX2C] NK homeobox (Drosophila), family 2, C;
  • Gene: [00.0/NKX2D] NK homeobox (Drosophila), family 2, D;
  • Gene: [00.0/NMT1] glycylpeptide N-tetradecanoyl transferase (N-myristoyltransferase);
  • Gene: [00.0/NNAT] neuronatin;
  • Gene: [00.0/NODAL] nodal (mouse) homolog; situs ambiguus;
  • Gene: [00.0/NOL2] nucleolar protein 2 (145kD); [NOP145 ]
  • Gene: [00.0/NONO] non-Pou domain-containing octamer (ATGCAAAT) binding protein;
  • Gene: [00.0/NOVA1] neuro-oncological ventral antigen 1;
  • Gene: [00.0/NOVA2] neuro-oncological ventral antigen 2;
  • Gene: [00.0/NPC2] Niemann-Pick disease, type C2 (minor form);
  • Gene: [00.0/NPMP1] nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogene 1;
  • Gene: [00.0/NPMP2] nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogene 2;
  • Gene: [00.0/NPMP3] nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogene 3;
  • Gene: [00.0/NPMP4] nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogene 4;
  • Gene: [00.0/NPMP5] nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogene 5;
  • Gene: [00.0/NPMP6] nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogene 6;
  • Gene: [00.0/NPMP7] nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogene 7;
  • Gene: [00.0/NRXN1] neurexin I alpha/beta;
  • Gene: [00.0/NRXN2] neurexin II alpha/beta;
  • Gene: [00.0/NRXN3] neurexin III alpha/beta;
  • Gene: [00.0/NSEP1] nuclease sensitive element binding protein 1;
  • Gene: [00.0/NT3] 3' nucleotidase;
  • Gene: [00.0/NT5CP] cytosolic purine 5'-nucleotidase;
  • Gene: [00.0/NTN1L] netrin 1 (chicken)-like;
  • Gene: [00.0/NTRKR1] neurotrophic tyrosine kinase receptor-related 1;
  • Gene: [00.0/NTRKR2] neurotrophic tyrosine kinase receptor-related 2;
  • Gene: [00.0/NTSR1] neurotensin receptor 1 (high affinity);
  • Gene: [00.0/NUCB2] nucleobindin 2; [NEFA ]
  • Gene: [00.0/NUP153] nucleoporin, 153kD;
  • Gene: [00.0/NUP62] nucleoporin, 62kD;
  • Gene: [00.0/NYS3] nystagmus 3, congenital autosomal dominant; [CN ]
  • Gene: [00.0/OCD1] obsessive-compulsive disorder 1;
  • Gene: [00.0/OCP1] organ of Corti protein 1;
  • Gene: [00.0/ODD] odd-skipped (Drosophila) homolog;
  • Gene: [00.0/OGN] osteoglycin (osteoinductive factor); [OIF ]
  • Gene: [00.0/OLR1] oxidised low density lipoprotein (lectin-like) receptor 1; [LOX-1 ]
  • Gene: [00.0/OPG] osteoprotegerin (osteoclastogenesis inhibitory factor); [OCIF ]
  • Gene: [00.0/OPRL1] opiod receptor-like 1;
  • Gene: [00.0/OPRS1] opioid receptor, sigma 1;
  • Gene: [00.0/OR2C1] olfactory receptor, family 2, subfamily C, member 1; [OLFmf3 ]
  • Gene: [00.0/ORW3] Osler-Rendu-Weber syndrome 3; telangiectasia, hereditary hemorrhagic, type III (HHT3); [HHT3 ]
  • Gene: [00.0/OVGP1] oviductal glycoprotein 1, 120kD;
  • Gene: [00.0/OVOL1] ovo (Drosophila) homolog-like 1;
  • Gene: [00.0/P2RX2] purinergic receptor P2X, ligand-gated ion channel, 2 (purinoceptor P2X2); [P2X2 ]
  • Gene: [00.0/P2RX5] purinergic receptor P2X, ligand-gated ion channel, 5 (purinoceptor P2X5);
  • Gene: [00.0/P2RX7] purinergic receptor P2X, ligand-gated ion channel, 7 (purinoceptor P2X7); [P2Z ]
  • Gene: [00.0/P47] pleckstrin (p47; platelet and leukocyte c kinase substrate);
  • Gene: [00.0/P4HBR] procollagen-proline, 2-oxyglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (protein disulfide isomerase)-related;
  • Gene: [00.0/P57] coronin-like protein p57 (actin-binding);
  • Gene: [00.0/P5CDH] pyrroline-5-carboxylate dehydrogenase, delta-1-; hyperprolinemia, type II (delta-1-pyrroline-5-carboxylate dehydrogenase deficiency);
  • Gene: [00.0/P67EIF2] eukaryotic initiation factor 2-associated protein (67kD); homologue of rat p67 translational initiation factor 2; methionine aminopeptidase 2 (peptidase M 2);
  • Gene: [00.0/PA2G4P] proliferation-associated 2G4 pseudogene;
  • Gene: [00.0/PAFAH1B2] platelet-activating factor acetylhydrolase, isoform Ib, beta subunit (30kD);
  • Gene: [00.0/PAFAH1B3] platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit (29kD);
  • Gene: [00.0/PAFAH2] platelet-activating factor acetylhydrolase 2 (intracellular; 40kD);
  • Gene: [00.0/PAICSP1] phosphoribosylaminoimidazole carboxylase (AIR carboxylase) pseudogene 1; phosphoribosylaminoimidazole succinocarboxamide synthetase (SAICAR synthetase) pseudogene 1;
  • Gene: [00.0/PAICSP2] phosphoribosylaminoimidazole carboxylase (AIR carboxylase) pseudogene 2; phosphoribosylaminoimidazole succinocarboxamide synthetase (SAICAR synthetase) pseudogene 2;
  • Gene: [00.0/PAK1] p21/Cdc42/Rac1-activated kinase 1 (yeast Ste20-related); serine/threonine kinase PAK-alpha;
  • Gene: [00.0/PAK3] p21/Cdc42/Rac1-activated kinase 3 (yeast Ste20-related); serine/threonine kinase PAK-gamma;
  • Gene: [00.0/PALM] paralemmin;
  • Gene: [00.0/PBEF] pre-B-cell colony-enhancing factor;
  • Gene: [00.0/PBM1] pre-B-cell monocytic leukemia partner 1;
  • Gene: [00.0/PBP] prostatic binding protein; phosphatidylethanolamine-binding protein (neuropolypeptide H3);
  • Gene: [00.0/PC4] activated RNA polymerase II transcription cofactor 4 (p15); [P15 ]
  • Gene: [00.0/PCDH3] protocadherin 3 (cadherin-like 3);
  • Gene: [00.0/PCDH8] protocadherin 8;
  • Gene: [00.0/PCDH9] protocadherin 9;
  • Gene: [00.0/PCK2] phosphoenolpyruvate carboxykinase 2 (mitochondrial); phosphoenolpyruvate carboxykinase deficiency;
  • Gene: [00.0/PCLD] polycystic liver disease; [PLD1 ]
  • Gene: [00.0/PCTK2] serine/threonine protein kinase PCTAIRE 2;
  • Gene: [00.0/PCYT2] phosphate cytidylyltransferase 2, ethanolamine;
  • Gene: [00.0/PDE1C] phosphodiesterase 1C, calcium/calmodulin-dependent (70kD);
  • Gene: [00.0/PDE2A] phosphodiesterase 2A, cGMP-stimulated;
  • Gene: [00.0/PDE3A] phosphodiesterase 3A, cGMP-inhibited; cyclic-AMP phosphodiesterase, myocardial, cGMP-inhibited;
  • Gene: [00.0/PDE8A] phosphodiesterase 8A;
  • Gene: [00.0/PDE9A] phosphodiesterase 9A;
  • Gene: [00.0/PDK1] pyruvate dehydrogenase kinase, isoenzyme 1;
  • Gene: [00.0/PDK2] pyruvate dehydrogenase kinase, isoenzyme 2 (p45);
  • Gene: [00.0/PDK3] pyruvate dehydrogenase kinase, isoenzyme 3;
  • Gene: [00.0/PEO3] progressive external ophthalmoplegia, type 3;
  • Gene: [00.0/PEX10] peroxisome biogenesis factor 10 (peroxin-10); peroxisome biogenesis disorder, complementation group 7; neonatal adrenoleukodystrophy (MIM:202370); Zellweger syndrome (MIM:214100); [CG7 NALD ]
  • Gene: [00.0/PEX12] peroxisome biogenesis factor 12 (peroxin-12); peroxisome biogenesis disorder (MIM:601539), complementation group 3;
  • Gene: [00.0/PEX13] peroxisome biogenesis factor 13 (peroxin-13);
  • Gene: [00.0/PEX14] peroxisome biogenesis factor 14 (peroxin-14);
  • Gene: [00.0/PFTK1] PFTAIRE protein kinase 1;
  • Gene: [00.0/PGGT1B] protein geranylgeranyltransferase type I, beta subunit;
  • Gene: [00.0/PGRP] progesterone receptor-associated protein, p23;
  • Gene: [00.0/PHKBP1] phosphorylase kinase, beta pseudogene 1;
  • Gene: [00.0/PHKBP2] phosphorylase kinase, beta pseudogene 2;
  • Gene: [00.0/PI10] protease inhibitor 10 (ovalbumin type, bomapin);
  • Gene: [00.0/PI13] protease inhibitor 13;
  • Gene: [00.0/PI14] protease inhibitor 14;
  • Gene: [00.0/PI8] protease inhibitor 8 (ovalbumin type); cytoplasmic antiproteinase 2 (CAP2); [CAP2 ]
  • Gene: [00.0/PIH] pregnancy-induced hypertension (pre-eclampsia, eclampsia, toxemia of pregnancy included);
  • Gene: [00.0/PIK3C2A] phosphatidylinositol 3-kinase, class 2, alpha polypeptide;
  • Gene: [00.0/PIK3C2G] phosphatidylinositol 3-kinase, class 2, gamma polypeptide;
  • Gene: [00.0/PIK3C3] phosphatidylinositol 3-kinase, class 3;
  • Gene: [00.0/PIK3CB] phosphatidylinositol 3-kinase, catalytic, beta polypeptide;
  • Gene: [00.0/PIK3CD] phosphatidylinositol 3-kinase, catalytic, delta polypeptide (p110-delta);
  • Gene: [00.0/PIK3CG] phosphatidylinositol 3-kinase, catalytic, gamma polypeptide;
  • Gene: [00.0/PIK4CA] phosphatidylinositol 4-kinase, catalytic, alpha (55kD);
  • Gene: [00.0/PIN] protein inhibitor of neuronal nitric oxide synthase;
  • Gene: [00.0/PIP5K2A] phosphatidylinositol-4-phosphate 5-kinase, type II, alpha;
  • Gene: [00.0/PIP5K3] phosphatidylinositol-4-phosphate 5-kinase, type III;
  • Gene: [00.0/PITPNB] phosphatidylinositol transfer protein, beta;
  • Gene: [00.0/PKD3] polycystic kidney disease, adult, type 3 (autosomal dominant);
  • Gene: [00.0/PKP2] plakophilin 2;
  • Gene: [00.0/PKP3] plakophilin 3;
  • Gene: [00.0/PLA2G4C] phospholipase A2, group IVC (cytosolic, calcium-independent), gamma;
  • Gene: [00.0/PLAGL1] pleiomorphic adenoma gene-like 1;
  • Gene: [00.0/PLAGL2] pleiomorphic adenoma gene-like 2;
  • Gene: [00.0/PLCB2] phospholipase C, beta 2;
  • Gene: [00.0/PLD2] phospholipase D2, phosphatidylcholine-specific;
  • Gene: [00.0/PLGAI2L1] plasminogen activator inhibitor, type II-like 1; [PAI2L1 ]
  • Gene: [00.0/PLGAI2L2] plasminogen activator inhibitor, type II-like 2; [PAI2L2 ]
  • Gene: [00.0/PLGP1] plasminogen pseudogene 1;
  • Gene: [00.0/PLGP2] plasminogen pseudogene 2;
  • Gene: [00.0/PLGRPB] plasminogen-related protein B;
  • Gene: [00.0/PLIN] perilipin;
  • Gene: [00.0/PLKG] plakoglobin (common junctional plaque protein);
  • Gene: [00.0/PLK] polo (Drosophia)-like kinase; serine/threonine-protein kinase PLK-1; serine/threonine-protein kinase 13;
  • Gene: [00.0/PLML] phospholemman-like protein (expressed in breast tumors, 8kD); chloride conductance inducer protein MAT-8; [MAT-8 ]
  • Gene: [00.0/PMAIP1] phorbol-12-myristate-13-acetate-induced protein 1;
  • Gene: [00.0/PMK] phosphomevalonate kinase (liver);
  • Gene: [00.0/PMS2L11] postmeiotic segregation increased 2-like 11; [PMSR6 ]
  • Gene: [00.0/PMS2LP2] postmeiotic segregation increased 2-like pseudogene 2; [PMSR7 ]
  • Gene: [00.0/PMSCL1] polymyositis/scleroderma autoantigen 1 (75kD);
  • Gene: [00.0/PMSCL2] polymyositis/scleroderma autoantigen 2 (100kD);
  • Gene: [00.0/PNLIPRP1] pancreatic lipase-related protein 1;
  • Gene: [00.0/PNLIPRP2] pancreatic lipase-related protein 2;
  • Gene: [00.0/PNMTP1] phenylethanolamine N-methyltransferase pseudogene 1;
  • Gene: [00.0/PNN] pinin, desmosome associated protein;
  • Gene: [00.0/POLG] polymerase (DNA directed), gamma (mitochondrial);
  • Gene: [00.0/POLH] polymerase (DNA directed), eta;
  • Gene: [00.0/POLR2F] RNA polymerase II (DNA directed) polypeptide F (14.4kD);
  • Gene: [00.0/POLR2H] RNA polymerase II (DNA directed) polypeptide H (17.1kD);
  • Gene: [00.0/POLR2J] RNA polymerase II (DNA directed) polypeptide J (13.3kD);
  • Gene: [00.0/POLR2K] RNA polymerase II (DNA directed) polypeptide K (7.0kD);
  • Gene: [00.0/POLR3A] RNA polymerase III (DNA directed) largest polypeptide;
  • Gene: [00.0/POU3F1] POU domain, class 3, transcription factor 1 (brain specific); [OTF6 OCT6 ]
  • Gene: [00.0/POU3F3] POU domain, class 3, transcription factor 3 (brain specific); [BRN1 OTF8]
  • Gene: [00.0/PPARAL] peroxisome proliferative activated receptor, alpha-like;
  • Gene: [00.0/PPATP1] phosphoribosyl pyrophosphate amidotransferase pseudogene 1;
  • Gene: [00.0/PPIC] peptidylprolyl cis-trans-isomerase C (cyclophilin C);
  • Gene: [00.0/PPIP1] peptidylprolyl cis-trans-isomerase (cyclophilin) pseudogene 1;
  • Gene: [00.0/PPIP5] peptidylprolyl cis-trans-isomerase (cyclophilin) pseudogene 5;
  • Gene: [00.0/PPIP7] peptidylprolyl cis-trans-isomerase (cyclophilin) pseudogene 7;
  • Gene: [00.0/PPIP8] peptidylprolyl cis-trans-isomerase (cyclophilin) pseudogene 8;
  • Gene: [00.0/PPM1A] protein phosphatase 1A, magnesium-dependent, alpha isoform;
  • Gene: [00.0/PPM1B] protein phosphatase 1B, magnesium-dependent, beta isoform;
  • Gene: [00.0/PPM1G] protein phosphatase 1G, magnesium-dependent, gamma isoform; protein phosphatase 2, catalytic subunit, gamma isoform;
  • Gene: [00.0/PPM2C] protein phosphatase 2C, magnesium-dependent, catalytic subunit;
  • Gene: [00.0/PPP1R1A] protein phosphatase 1, regulatory subunit 1A (inhibitor);
  • Gene: [00.0/PPP1R1B] protein phosphatase 1, regulatory subunit 1B (inhibitor); dopamine and cAMP regulated phosphoprotein (DARPP-32);
  • Gene: [00.0/PPP1R3] protein phosphatase 1, regulatory subunit 3 (inhibitor);
  • Gene: [00.0/PPP1R6] protein phosphatase 1, regulatory subunit 6 (inhibitor; spinophilin);
  • Gene: [00.0/PPP1R8P] protein phosphatase 1, regulatory subunit 8 pseudogene;
  • Gene: [00.0/PPP1R8] protein phosphatase 1, regulatory subunit 8 (inhibitor); nuclear inhibitor of protein phosphatase 1 (NIPP1); activator of RNA decay (ARD1); RNase E (E.coli) homolog;
  • Gene: [00.0/PPP2R1A] protein phosphatase 2, regulatory subunit A (PR 65), alpha isoform;
  • Gene: [00.0/PPP2R1B] protein phosphatase 2, regulatory subunit A (PR 65), beta isoform;
  • Gene: [00.0/PPP2R2A] protein phosphatase 2, regulatory subunit B (PR 52), alpha isoform;
  • Gene: [00.0/PPP2R2B] protein phosphatase 2, regulatory subunit B (PR 52), beta isoform;
  • Gene: [00.0/PPP2R2C] protein phosphatase 2, regulatory subunit B (PR 52), gamma isoform;
  • Gene: [00.0/PPP2R3] protein phosphatase 2, regulatory subunit B'' (PR 72) alpha isoform; protein phosphatase 2, regulatory subunit B'' (PR 130), beta isoform;
  • Gene: [00.0/PPP3R2] protein phosphatase 3, regulatory subunit B (19kD), beta isoform;
  • Gene: [00.0/PRG2] proteoglycan 2, bone marrow; natural killer cell activator; eosinophil granule major basic protein;
  • Gene: [00.0/PRKA1] protein kinase A1;
  • Gene: [00.0/PRKA2] protein kinase A2;
  • Gene: [00.0/PRKAB2] protein kinase, AMP-activated, beta 2 non-catalytic subunit;
  • Gene: [00.0/PRKACN1] protein kinase, cAMP-dependent, catalytic subunit, inhibitor 1;
  • Gene: [00.0/PRKACN2] protein kinase, cAMP-dependent, catalytic subunit, inhibitor 2;
  • Gene: [00.0/PRKAG2] protein kinase, AMP-activated, gamma 2 non-catalytic subunit;
  • Gene: [00.0/PRKAR2A] protein kinase, cAMP-dependent, regulatory subunit, type II, alpha;
  • Gene: [00.0/PRKCE] protein kinase C, epsilon polypeptide;
  • Gene: [00.0/PRKCH] protein kinase C, eta polypeptide;
  • Gene: [00.0/PRKCL2] protein kinase C-like 2;
  • Gene: [00.0/PRKCZ] protein kinase C, zeta polypeptide;
  • Gene: [00.0/PRKM11] protein kinase, mitogen-activated 11; stress-activated protein kinase 2B;
  • Gene: [00.0/PRKM13] protein kinase, mitogen-activated 13; stress-activated protein kinase 4;
  • Gene: [00.0/PRKM7] protein kinase, mitogen-activated 7; MAP kinase 7;
  • Gene: [00.0/PRKMK2] protein kinase, mitogen-activated, kinase 2 (45kD); MAP kinase kinase 2 (MAPKK 2);
  • Gene: [00.0/PRKMK5] protein kinase, mitogen-activated, kinase 5; MAP kinase kinase 5 (MAPKK 5);
  • Gene: [00.0/PRKMK6] protein kinase, mitogen-activated, kinase 6; MAP kinase kinase 6 (MAPKK 6);
  • Gene: [00.0/PRKMK7] protein kinase, mitogen-activated, kinase 7; MAP kinase kinase 7 (MAPKK 7); JNK-activating kinase 2;
  • Gene: [00.0/PRO1] progeria 1 (Hutchinson-Gilford type);
  • Gene: [00.0/PROCR] protein C receptor (endothelial);
  • Gene: [00.0/PROZ] protein Z (vitamin K-dependent);
  • Gene: [00.0/PRP4] serine/threonine-protein kinase Prp4 (S.pombe) homolog;
  • Gene: [00.0/PRPSAP1] phosphoribosyl pyrophosphate synthetase-associated protein 1;
  • Gene: [00.0/PRR1] proline-rich polypeptide 1 (prostatic);
  • Gene: [00.0/PRRG1] proline-rich Gla (G-carboxyglutamic acid) polypeptide 1; [PRGP1 ]
  • Gene: [00.0/PRRG2] proline-rich Gla (G-carboxyglutamic acid) polypeptide 2; [PRGP2 ]
  • Gene: [00.0/PRSM2] protease, metallo, 2;
  • Gene: [00.0/PRSS3] protease, serine, 3 (trypsin 3);
  • Gene: [00.0/PRSS4] protease, serine, 4a (trypsin 4a, brain);

    •